How did you decide to participate in the Biomapas Academy?
When I used to walk past a pharmacy every day, I could never stop dreaming about being able to help people and develop innovative pharmaceuticals. So while studying biomedical sciences, I became interested in the drug development paths, which led me to medicinal chemistry. And one day at the university, I saw a poster about the Biomapas Academy, which could help me understand what, how, where, and when happens to pharmaceutical products during the whole journey to reach us, so I signed up for it without hesitation. Even though I am usually not a lucky person, I was selected to be one of the participants, which surprised me!
How was your experience regarding the Academy?
During the few months, I deepened my existing knowledge of drug development stages and expanded it to learn more about drug regulation and pharmacovigilance. After graduating from the Academy, I got the opportunity to try out regulatory affairs as part of Biomapas – I completed a summer internship in the Regulatory Affairs department.
How do you feel after graduating from the Academy?
I will never forget this practice in my life, not only because it fulfilled what I was looking for, but it let me realize that I want to return to this company after my graduation and put my accumulated knowledge to use. Thanks again to all Biomapas staff for their insights and advice, and I hope to see you soon.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Dossier Transformation for Market Expansion
Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...
Whitepaper: Computerised System Validation & Pharmacovigilance
This whitepaper explores how optimised computer system validation (CSV) strategies strengthen risk management, ensure data integrity in pharmacovigilance systems, and support compliance through a real-world cloud-based safety database case study.
Unlock Trial Success with the FSP Hybrid Model
Learn how the FSP hybrid model combines the best of FSO and FSP in clinical trials, enhancing operational control and flexibility.
Breaking silos across Medical Information & Pharmacovigilance
Discover solutions for effective PV & MI data management, including handling Adverse Events, Product Quality Complaints, and MI inquiries. Our experts will walk you through real-life examples and hands-on solutions.
Unlocking Success. The FSP Advantage in Clinical Research
FSP is a rising trend in clinical research, expected to gain further prominence due to its cost-effectiveness and demand for specialised expertise. Our FSP model offers benefits such as cost savings, expert advice, flexibility, and risk mitigation. Let’s discuss how...
Affiliate Based Outsourcing Model for Regulatory Affairs.
Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different...
Regulatory Outsourcing in the CEE Region
In this informative session we decode the intricate landscape of regulatory affairs outsourcing in the CEE region and provide practical, implementable strategies to optimize and maximize your operations and outsourcing strategies.Let’s discuss how we can streamline...
Regulatory Framework of Drugs in MENA: Insights
In this webinar, our experts discuss regulatory affairs of medicinal products. Two aspects that have recently gained increasing importance among the various stakeholders, namely the eCTD implementation across the region and the serialization and barcoding requirements...
How to Set Up and Manage Local Pharmacovigilance Networks for Global Compliance
Structure compliant local PV networks while maintaining centralized oversight, from regulatory obligations, partner selection, QPPV responsibilities, technology integration and outsourcing within a scalable strategy.
How medical writing supports every stage of the drug’s lifecycle
Discover how medical writing for clinical trials supports each phase of drug development with essential documentation.
